Publication | Closed Access
Volociximab, a chimeric integrin alpha5beta1 antibody, inhibits the growth of VX2 tumors in rabbits
62
Citations
16
References
2007
Year
Vx2 TumorsImmunologyTherapeutic EfficacyImmunotherapyMedicineRadiation OncologyTumor BiologyCancer Growth
| Year | Citations | |
|---|---|---|
Page 1
Page 1